Cargando…
Subcutaneous Emphysema and Pneumomediastinum Following Non-invasive Ventilation in a Patient With Severe COVID-19 Disease
Subcutaneous emphysema (SE) and pneumomediastinum are rare complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While SE is often non-fatal and usually self-remitting, pneumomediastinum can be fatal with high mortality rates depending on the underlying etiology. Here, we pr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321423/ https://www.ncbi.nlm.nih.gov/pubmed/34336526 http://dx.doi.org/10.7759/cureus.16051 |
_version_ | 1783730847248023552 |
---|---|
author | Tata, Ravichandra Bingi, Thrilok Chander Maurya, Akhilesh Kumar Kalakuntla, Hemanth Gangishetti, Saketh |
author_facet | Tata, Ravichandra Bingi, Thrilok Chander Maurya, Akhilesh Kumar Kalakuntla, Hemanth Gangishetti, Saketh |
author_sort | Tata, Ravichandra |
collection | PubMed |
description | Subcutaneous emphysema (SE) and pneumomediastinum are rare complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While SE is often non-fatal and usually self-remitting, pneumomediastinum can be fatal with high mortality rates depending on the underlying etiology. Here, we present the case of a 39-year-old otherwise healthy male who tested positive for SARS-CoV-2. The patient was treated with non-invasive mechanical ventilation (NIMV) and developed severe SE and pneumomediastinum which resulted in a fatal outcome. Although the exact pathogenesis could not be determined, the extensive lung injury caused by SARS-CoV-2 pneumonia along with possible barotrauma secondary to NIMV could have been the culprits in this case. Early detection through careful observation of these potentially fatal complications in patients with severe coronavirus disease 2019 is crucial. Further studies determining the potential risk factors and incidence of SE and pneumomediastinum, especially in patients receiving invasive mechanical ventilation or NIMV, are needed. |
format | Online Article Text |
id | pubmed-8321423 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-83214232021-07-31 Subcutaneous Emphysema and Pneumomediastinum Following Non-invasive Ventilation in a Patient With Severe COVID-19 Disease Tata, Ravichandra Bingi, Thrilok Chander Maurya, Akhilesh Kumar Kalakuntla, Hemanth Gangishetti, Saketh Cureus Internal Medicine Subcutaneous emphysema (SE) and pneumomediastinum are rare complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While SE is often non-fatal and usually self-remitting, pneumomediastinum can be fatal with high mortality rates depending on the underlying etiology. Here, we present the case of a 39-year-old otherwise healthy male who tested positive for SARS-CoV-2. The patient was treated with non-invasive mechanical ventilation (NIMV) and developed severe SE and pneumomediastinum which resulted in a fatal outcome. Although the exact pathogenesis could not be determined, the extensive lung injury caused by SARS-CoV-2 pneumonia along with possible barotrauma secondary to NIMV could have been the culprits in this case. Early detection through careful observation of these potentially fatal complications in patients with severe coronavirus disease 2019 is crucial. Further studies determining the potential risk factors and incidence of SE and pneumomediastinum, especially in patients receiving invasive mechanical ventilation or NIMV, are needed. Cureus 2021-06-30 /pmc/articles/PMC8321423/ /pubmed/34336526 http://dx.doi.org/10.7759/cureus.16051 Text en Copyright © 2021, Tata et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Tata, Ravichandra Bingi, Thrilok Chander Maurya, Akhilesh Kumar Kalakuntla, Hemanth Gangishetti, Saketh Subcutaneous Emphysema and Pneumomediastinum Following Non-invasive Ventilation in a Patient With Severe COVID-19 Disease |
title | Subcutaneous Emphysema and Pneumomediastinum Following Non-invasive Ventilation in a Patient With Severe COVID-19 Disease |
title_full | Subcutaneous Emphysema and Pneumomediastinum Following Non-invasive Ventilation in a Patient With Severe COVID-19 Disease |
title_fullStr | Subcutaneous Emphysema and Pneumomediastinum Following Non-invasive Ventilation in a Patient With Severe COVID-19 Disease |
title_full_unstemmed | Subcutaneous Emphysema and Pneumomediastinum Following Non-invasive Ventilation in a Patient With Severe COVID-19 Disease |
title_short | Subcutaneous Emphysema and Pneumomediastinum Following Non-invasive Ventilation in a Patient With Severe COVID-19 Disease |
title_sort | subcutaneous emphysema and pneumomediastinum following non-invasive ventilation in a patient with severe covid-19 disease |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321423/ https://www.ncbi.nlm.nih.gov/pubmed/34336526 http://dx.doi.org/10.7759/cureus.16051 |
work_keys_str_mv | AT tataravichandra subcutaneousemphysemaandpneumomediastinumfollowingnoninvasiveventilationinapatientwithseverecovid19disease AT bingithrilokchander subcutaneousemphysemaandpneumomediastinumfollowingnoninvasiveventilationinapatientwithseverecovid19disease AT mauryaakhileshkumar subcutaneousemphysemaandpneumomediastinumfollowingnoninvasiveventilationinapatientwithseverecovid19disease AT kalakuntlahemanth subcutaneousemphysemaandpneumomediastinumfollowingnoninvasiveventilationinapatientwithseverecovid19disease AT gangishettisaketh subcutaneousemphysemaandpneumomediastinumfollowingnoninvasiveventilationinapatientwithseverecovid19disease |